Clinical effects of capsules containing Trametes versicolor extract

Preparation of capsule form of hot water polysaccharide rich extract from Trametes versicolor and effect of it on blood factors in diabetic patients. A Double-Blind, Randomized Clinical Trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20161205031242N3

Enrollment

Registered

2021-02-11

Start date

2021-01-03

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: 6 capsules of 500 mg containing 250 mg of Trametes versicolor mushroom extract powder in three meals a day for 2 months. Intervention 2: Control group: 6 placebo capsules containing 50

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Age between 20 and 50 years diagnosis of type 2 diabetes for more than 2 years No kidney disease No liver disease No parathyroid disease No gastrointestinal diseases No inflammatory diseases

Exclusion criteria

Exclusion criteria: Pregnancy and lactation use of insulin Use of nonsteroidal anti-inflammatory drugs smoking alcohol consumption people who follow weight loss diets

Design outcomes

Primary

Measure	Time frame
Blood factors in diabetic patients. Timepoint: before and after treatment. Method of measurement: blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Emran Habibi

Mazandaran University of Medical Sciences

emrapharm@yahoo.com+98 11 3354 3695

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026